NCT04540588View on ClinicalTrials.gov

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

NARecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2026

Conditions
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (1)

91120

RECRUITING

Sharett institute, Hadassah University Hospital - Ein-Kerem, Jerusalem

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY

NCT04540588 - Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | Biotech Hunter | Biotech Hunter